A Proposal for Structured Abstracts of Health Economic Studies

Elixhauser A Halpern M Schmier J Luce M . Health care CBA and CEA from 1991 to 1996: An updated bibliography. Med Care 1998;36:MS1–9.

Bradley CA Iskedjian M Lanctôt KL Mittmann N Simone C St. Pierre E Quality assessment of economic evaluations in selected pharmacy, medical, and health economics journals. Ann Pharmacother 1995;29:681–9.

Relman A . New “information for authors” — And readers (editorial). N Engl J Med 1990;323:56.

Taddio A Pain T Fassos F Boon H Ilersich A Einarson T . Quality of nonstructured and structured abstracts of original research in the British Medical Journal, Canadian Medical Association Journal and the Journal of the American Medical Association . Can Med Assoc J 1994;150: 1611–5.

Soffer A . Abstracts of clinical investigations: A new and standardized format. Chest 1987;92:389–90.

Misiewicz J . Summaries of papers reporting results of clinical trials. Gut 1988;29:273–4.

Lock S . Structured abstracts: Now required for all papers reporting clinical trials (editorial). BMJ 1988;297:156.

Huth E . Structured abstracts for papers reporting clinical trials (editorial). Ann Intern Med 1987;106:626–7.

Mulrow C Thacker S Pugh J . A proposal for more informative abstracts of review articles. Ann Intern Med 1988;108:613–5.

Squires B . Structured abstracts of original research and review articles. Can Med Assoc J 1990;143:619–22.

Squires B Keith R Meakins J . Structured abstracts for clinical research manuscripts and reviews. Can J Surg 1992;35:473–5.

Trakas K Addis A Kruk D Buczek Y Iskedjian M Einarson TR . Quality assessment of pharmacoeconomic abstracts of original research articles in selected journals. Ann Pharmacother 1997;31:423–8.

Siegel JE Weinstein MC Torrance GW . Reporting cost-effectiveness studies and results. In: Gold MR Siegel JE Russell LB Weinstein MC , eds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996:276–303.

Siegel J Weinstein M Russell LB Gold M , Panel for Cost Effectiveness for Health and Medicine. Recommendation for the reporting cost-effectiveness analyses. JAMA 1996;276:1339–41.

Ad Hoc Working Group for Critical Appraisal of the Medical Literature. A proposal for more informative abstracts of clinical articles. Ann Intern Med 1987;106:598–604.

Canadian Coordinating Office for Health Technology Assessment (CCO-HTA). Guidelines for economic evaluation of pharmaceuticals: Canada. 2nd ed. Toronto: Ontario Ministry of Health, 1997.

Ontario Ministry of Health. Ontario guidelines for economic analysis of pharmaceutical products. Toronto: Ontario Ministry of Health.

England and Wales Department of Health. Guidelines on good practice in the conduct of economic evaluation of medicines. London: Department of Health, 1994.

Australia Commonwealth Department of Health and Housing and Community Services. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee. Canberra, Australia: Commonwealth Department, 1992.

Langley PC . The November 1995 revised Australian guidelines for the economic evaluation of pharmaceuticals. PharmacoEconomics 1996;9: 341–52.

Gold MR Siegel JE Russell LB Weinstein MC , eds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996.

Siegel JE Torrance GW Russell LB Luce BR Weinstein MC Gold M Guidelines for pharmacoeconomic studies. PharmacoEconomics 1997;11:159–68.

Torrance GW Blaker D Detsky A Kennedy W Schubert F Menon D Canadian guidelines for economic evaluation of pharmaceuticals. PharmacoEconomics 1996;9:535–59.

Weinstein MC Siegel JE Gold MR Kamlet MS Russell LB , Panel on Cost-Effectiveness in Health and Medicine. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996;276: 1253–8.

Clemens K Townsend R Luscombe F Mauskopf J Osterhaus J Bobula J . Methodological and conduct principles for pharmacoeconomic research. PharmacoEconomics 1995;8:169–74.

Garattini L Grilli R Scopelliti D Mantovani L . A proposal for Italian guidelines in pharmacoeconomics. PharmacoEconomics 1995;7:1–6.

Ikeda S Ikegami N Oliver AJ Ikeda M . A case for the adoption of pharmacoeconomic guidelines in Japan. PharmacoEconomics 1996;10:546–51.

Rovira J Antonanzas F . Economic analysis of health technologies and programmes: A Spanish proposal for methodological standardisation. PharmacoEconomics 1995;8:245–52.

Drummond MF Stoddart GL Torrance GW . Methods for the economic evaluation of healthcare programs. Oxford: Oxford Medical Publications, 1987.

Jolicoeur LM Jones-Grizzle AJ Boyer JG . Guidelines for performing a pharmacoeconomic analysis. Am J Hosp Pharm 1992;49:1741–7.

Freund DA Dittus RS . Principles of pharmacoeconomic analysis of drug therapy. PharmacoEconomics 1992;1:20–32.

Eisenberg JM . Clinical economics: A guide to the economic analysis of clinical practices. JAMA 1989;262:2879–86.

Luce BR Simpson K . Methods of cost-effectiveness analysis: Areas of consensus and debate. Clin Ther 1995;17:109–25.

Sanchez LA . Evaluating the quality of published pharmacoeconomic evaluations. Hosp Pharm 1995;30:151–2.

Sacristán JA Soto J Galende I . Evaluation of pharmacoeconomic studies: Utilization of a checklist. Ann Pharmacother 1993;27:1126–33.

McGhan WF Lewis NJW . Issues in health policy: Guidelines for pharmacoeconomic studies. Clin Ther 1992;14:486–94.

Guyatt G Drummond M Feeny D Tugwell P Stoddart G Haynes RB Guidelines for the clinical and economic evaluation of health care technologies. Soc Sci Med 1986;22:393–408.